Page last updated: 2024-12-07

3,4-dihydroxyphenylacetaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4-Dihydroxyphenylacetaldehyde, also known as dopamine-β-hydroxylase (DBH) substrate, is an important intermediate in the biosynthesis of norepinephrine. It is synthesized from dopamine by the enzyme dopamine β-hydroxylase. 3,4-Dihydroxyphenylacetaldehyde is a potent inhibitor of monoamine oxidase (MAO) activity, which is an enzyme that breaks down neurotransmitters like dopamine, norepinephrine, and serotonin. This inhibition leads to increased levels of these neurotransmitters in the brain, which can have significant effects on mood, cognition, and behavior. 3,4-Dihydroxyphenylacetaldehyde has been studied for its potential therapeutic effects in conditions such as depression, anxiety, and Parkinson's disease. It has also been investigated for its potential as a neuroprotective agent in brain injury and stroke.'
```

3,4-dihydroxyphenylacetaldehyde : A phenylacetaldehyde in which the 3 and 4 positions of the phenyl group are substituted by hydroxy groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID119219
CHEBI ID27978
SCHEMBL ID891837
MeSH IDM0050630

Synonyms (25)

Synonym
CHEBI:27978
(3,4-dihydroxyphenyl)acetaldehyde
2-(3,4-dihydroxyphenyl)ethanal
5707-55-1
dopal
C04043
3,4-dihydroxyphenylacetaldehyde
protocatechuatealdehyde
2-(3,4-dihydroxyphenyl)acetaldehyde
benzeneacetaldehyde, 3,4-dihydroxy-
unii-f2e9q24tsl
f2e9q24tsl ,
gtpl6632
SCHEMBL891837
AKOS022634762
DTXSID10205680
3,4-dihydroxy-benzeneacetaldehyde
Q4634065
A902925
dopal (>80%)
SY237352
mfcd19707262
2-(3,4-bis(oxidanyl)phenyl)ethanal
3,4-dihydroxybenzeneacetaldehyde
EN300-732949

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"3,4-Dihydroxyphenylacetaldehyde (DOPAL) is a toxic metabolite formed by the oxidative deamination of dopamine."( 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Eisenhofer, G; Harvey-White, J; Kirk, K; Kopin, IJ; Lamensdorf, I; Nechustan, A, 2000
)
3.19
" So, these results suggest that an early production of DOPAL could produce delayed toxic effects on SH-SY5Y cells."( Toxicity of a treatment associating dopamine and disulfiram for catecholaminergic neuroblastoma SH-SY5Y cells: relationships with 3,4-dihydroxyphenylacetaldehyde formation.
Bonnet, JJ; Costentin, J; Dingeval, MG; Janin, F; Legros, H, 2004
)
0.53
" Although this effect occurs with the formation of differently toxic products, the molecular basis of this inhibition is still unclear."( Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Acquasaliente, L; Bucciantini, M; Fongaro, B; Leri, M; Palazzi, L; Polverino de Laureto, P; Stefani, M, 2021
)
0.62
" DOPAL is well known to exhibit toxic effects on neuronal cells."( Oxidative Transformations of 3,4-Dihydroxyphenylacetaldehyde Generate Potential Reactive Intermediates as Causative Agents for Its Neurotoxicity.
Ito, S; Ojika, M; Sugumaran, M; Tanaka, H; Wakamatsu, K, 2021
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
phenylacetaldehydes
catecholsAny compound containing an o-diphenol component.
alpha-CH2-containing aldehydeAn aldehyde of general formula R-CH2-CH=O in which the aldehydic C=O function is attached to a CH2 group at the alpha-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (18)

PathwayProteinsCompounds
Tyrosine Metabolism1657
Alkaptonuria1657
Hawkinsinuria1657
Tyrosinemia Type I1657
Disulfiram Action Pathway2366
Tyrosinemia, Transient, of the Newborn1657
Dopamine beta-Hydroxylase Deficiency1657
Monoamine Oxidase-A Deficiency (MAO-A)1657
Isoquinoline Alkaloid Biosynthesis513
Tyrosine metabolism ( Tyrosine metabolism )2841
NAD+ + 3,4-Dihydroxy-phenyl-acetaldehyde + H2O = NADH + 3,4-Dihydroxy-phenyl-acetic acid ( Tyrosine metabolism )45
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
Involvement of -secretase in neurodegenerative diseases162
(S)-reticuline biosynthesis116
dopamine degradation431
aromatic biogenic amine degradation (bacteria)335
(S)-reticuline biosynthesis II117
Dopamine metabolism032

Research

Studies (94)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (15.96)18.7374
1990's5 (5.32)18.2507
2000's22 (23.40)29.6817
2010's41 (43.62)24.3611
2020's11 (11.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.00 (24.57)
Research Supply Index4.61 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews12 (12.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (87.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]